Melanoma Immunotherapy: Promising against Cancer Cells Growth and for Survival Increase?

Treatment options for advanced cutaneous melanoma remain limited. Yet, melanoma represents only 2-4% of all malignant tumors but remains the most deadly type of skin cancer worldwide (> 50.000 deaths annually equivalent to 75% of all cutaneous cancer-related deaths) due to systemic metastatic spread (about 12% of the cases). The incidence of malignant melanoma has increased fivefold from 1980 to 2009 in Brazil.